Invest in Vast Therapeutics

CLOSED

The Future of Respiratory Medicine

This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

REASONS TO INVEST

ABOUT

HEADQUARTERS

TERMS

Vast Therapeutics

Overview

PRICE PER SHARE

$1.04

DEADLINE

Mar. 18, 2025 at 6:59 AM UTC

VALUATION

$49.85M

FUNDING GOAL

$20.8K - $1.24M

Breakdown

MIN INVESTMENT

$468

MAX INVESTMENT

$1,235,000

MIN NUMBER OF SHARES OFFERED

20,000

MAX NUMBER OF SHARES OFFERED

1,187,500

OFFERING TYPE

Equity

SHARES OFFERED

Series B Preferred Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Most Recent Fiscal Year-End

Prior Fiscal Year-End

Total Assets

$44,528,729

$46,919,554

Cash & Cash Equivalents

$98,317

$72,331

Accounts Receivable

$141,320

Short-Term Debt

$1,806,998

$236,746

Long-Term Debt

$9,958,976

$6,822,479

Revenue & Sales

$737,317

Costs of Goods Sold

Taxes Paid

Net Income

-$7,536,758

-$6,326,741

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Loyalty Bonus | 20% Bonus Shares

As you are a valued stakeholder in KNOW Bio, LLC or a designated friend/family member of the Vast Therapeutics team, you are eligible for 20% additional bonus shares on top of your investment.

Time-Based Perks

Early Bird 1

Invest $5,000+ within the first week and receive 5% bonus shares.

Early Bird 2

Invest $10,000+ within the first week and receive 10% bonus shares.

Early Bird 3

Invest $15,000+ within the first month and receive 10% bonus shares.

Early Bird 4

Invest $50,000+ within the first month and receive 15% bonus shares.

Amount-Based Perks

Tier 1

Invest $1,000 and be eligible to receive a quarterly newsletter from the CEO tailored to the StartEngine shareholder base and 3% bonus shares

Tier 2

Invest $7,500 and receive 5% bonus shares

Tier 3

Invest $25,000 and receive a private virtual Q&A with the CEO and 10% bonus shares

Tier 4

Invest $100,000 and receive a VIP invitation for an onsite tour of the research lab, lunch and Q&A with the Vast management team, and 15% bonus shares

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed. Crowdfunding investments made through a self-directed IRA cannot receive perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those perks because they would be receiving a benefit from their IRA account.

The 10% StartEngine Venture Club Bonus

Vast Therapeutics, Inc. will offer 10% additional bonus shares for all investments that are committed by investors who are eligible for the StartEngine Venture Club.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Series B Preferred Stock at $1.04/ share, you will receive 110 shares of Series B Preferred Stock, meaning you’ll own 110 shares for $104. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor’s eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and the time of offering elapsed (if any). Eligible investors will also receive the Venture Club Bonus and the Loyalty Bonus in addition to the aforementioned bonus.

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

More FAQs